Wegovy Can Treat a Dangerous Liver Disease, Study Finds

New research shows that semaglutide, the compound in the weight-loss drug Wegovy, could treat an increasingly common liver disease. The study, published Wednesday in the New England Journal of Medicine, included 800 adults with a severe form of liver disease known as metabolic dysfunction-associated steatohepatitis, or MASH. People develop MASH after fat builds up in…

Read More

Digital Therapists Get Stressed Too, Study Finds

Even chatbots get the blues. According to a new study, OpenAI’s artificial intelligence tool ChatGPT shows signs of anxiety when its users share “traumatic narratives” about crime, war or car accidents. And when chatbots get stressed out, they are less likely to be useful in therapeutic settings with people. The bot’s anxiety levels can be…

Read More